Research has shown that migraines are linked to inflammation.
A clinical trial examined Coenzyme Q10βs (CoQ10βs) effects on episodic migraines in women, finding significant reductions in migraine frequency, duration, severity. CoQ10 also reduced the levels of TNF-Ι and CGRP, a peptide linked to migraines that promotes inflammation and pain signaling.
AΒ meta-analysis of five studies concluded that CoQ10 supplementation is more effective than a placebo in reducing migraine occurrence and duration in both children and adults.
βThe results support the use of CoQ10 as a potent therapeutic agent with respect to migraine duration and migraine days/month.β (Zeng et al., 2018)
These findings were corroborated in a subsequent meta-analysis of six clinical trials that showed CoQ supplemented as a preventative measure was effective for reducing the duration and frequency of migraines.
Leading the companyβs engagement in transformative research. She is committed to scientific integrity in the health and wellness space and data transparency with consumers.
She holds a Ph.D. in Biochemical and Molecular Nutrition from Tufts University and has over ten years of nutrition science research experience, exploring various dimensions of human well-being in academic and government laboratories.
Once regarded as a simple coenzyme required for energy production, NADβΊ is now recognized as a master regulator of health, supporting DNA repair, epigenetic programming, immune responses, and mitochondrial function....
CoQ10: The Cellular Protector Direct antioxidant action. Ubiquinol scavenges free radicals before they can cause damage, protecting mitochondria, proteins, and DNA from oxidative damage. (2) Antioxidant recycling. CoQ10 regenerates vitamin...
A groundbreaking new study from UC Berkeley reports that combining oxytocin (OT) with an Alk5 inhibitor (A5i) dramatically extended lifespan and healthspan in old frail male mice - showing the...
Skip to content
